Norbrook has announced the appointment of Richard Palmer as Global Head of Sales & Marketing, with effect from the beginning of February 2015.
Richard joins Norbrook from Novartis, where he has had a long and distinguished career, most recently as Chief Marketing Officer for its Animal Health business.
Commenting on the appointment, CEO Liam Nagle said Norbrook is delighted to welcome Richard to the team. “He brings a wide range of skills and experience which will be of great benefit to the team in Norbrook. Richard has 30 years’ commercial experience in the pharmaceutical sector, 24 of which specifically in the animal health business.
“Norbrook has a strong track record of innovation and growth, and we look forward to working with Richard as we continue to develop our business.”
Norbrook develops and manufactures veterinary and animal health medicines. It is the only company in the World licensed by the United States Food & Drugs Administration (USFDA) to manufacture sterile injections for veterinary use outside USA and import them for sale in USA territory.
The Group is privately owned by the Haughey family and was originally founded by the late Lord Ballyedmond in 1969.
The Norbrook group is now present in 115 countries with sales of £210m in the Company’s most recent financial year to July 2014.